A carregar...
Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree
BACKGROUND: The results of two randomized phase 3 trials that investigated the use of laquinimod in patients with relapsing-remitting multiple sclerosis were analyzed using a propensity score model. METHODS: The propensity score in each study was defined as the probability of an individual patient b...
Na minha lista:
| Publicado no: | BMC Neurol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5027083/ https://ncbi.nlm.nih.gov/pubmed/27639853 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12883-016-0702-4 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|